Works matching IS 00071188 AND DT 2017 AND VI 174 AND IP 24

Results: 27

Shikonin inhibits myeloid differentiation protein 2 to prevent LPS-induced acute lung injury.

Published in:

2017

By:

Zhang, Yali;
Xu, Tingting;
Pan, Zheer;
Ge, Xiangting;
Sun, Chuchu;
Lu, Chun;
Chen, Hongjin;
Xiao, Zhongxiang;
Zhang, Bing;
Dai, Yuanrong;
Liang, Guang

Publication type:

journal article

Finding the needle in the haystack: systematic identification of psychobiotics.

Published in:

2017

By:

Bambury, Aisling;
Sandhu, Kiran;
Cryan, John F;
Dinan, Timothy G

Publication type:

journal article

Mirabegron: potential off target effects and uses beyond the bladder.

Published in:

2017

By:

Dehvari, Nodi;
da Silva Junior, Edilson Dantas;
Bengtsson, Tore;
Hutchinson, Dana S;
Hutchinson, Dana Sabine

Publication type:

journal article

No pain, no gain: balancing central versus peripheral benefits of analgesics in the age of the opioid crisis.

Published in:

2017

By:

Patel, Hemal H;
Roth, David M

Publication type:

journal article

VPAC1 and VPAC2 receptor activation on GABA release from hippocampal nerve terminals involve several different signalling pathways.

Published in:

2017

By:

Cunha‐Reis, Diana;
Ribeiro, Joaquim Alexandre;
Almeida, Rodrigo F M;
Sebastião, Ana M;
Cunha-Reis, Diana;
de Almeida, Rodrigo F M;
Sebastião, Ana M

Publication type:

journal article

BIO 300, a nanosuspension of genistein, mitigates pneumonitis/fibrosis following high-dose radiation exposure in the C57L/J murine model.

Published in:

2017

By:

Jackson, Isabel L;
Zodda, Andrew;
Gurung, Ganga;
Pavlovic, Radmila;
Kaytor, Michael D;
Kuskowski, Michael A;
Vujaskovic, Zeljko

Publication type:

journal article

Dopamine D2 receptor signalling controls inflammation in acute pancreatitis via a PP2A-dependent Akt/NF-κB signalling pathway.

Published in:

2017

By:

Han, Xiao;
Li, Bin;
Ye, Xin;
Mulatibieke, Tunike;
Wu, Jianghong;
Dai, Juanjuan;
Wu, Deqing;
Ni, Jianbo;
Zhang, Ruling;
Xue, Jing;
Wan, Rong;
Wang, Xingpeng;
Hu, Guoyong

Publication type:

journal article

Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.

Published in:

British Journal of Pharmacology, 2017, v. 174, n. 24, p. 4771, doi. 10.1111/bph.14059

By:

Samidurai, Arun;
Salloum, Fadi N;
Durrant, David;
Chernova, Olga B;
Kukreja, Rakesh C;
Das, Anindita

Publication type:

Article

Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease.

Published in:

2017

By:

Toledo, Enrique M;
Gyllborg, Daniel;
Arenas, Ernest

Publication type:

journal article

WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.

Published in:

2017

By:

Driehuis, Else;
Clevers, Hans

Publication type:

journal article

Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.

Published in:

2017

By:

Janovská, Pavlína;
Bryja, Vítězslav;
Janovská, Pavlína;
Bryja, Vítězslav

Publication type:

journal article

Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.

Published in:

British Journal of Pharmacology, 2017, v. 174, n. 24, p. 4666, doi. 10.1111/bph.13890

By:

Flanagan, Dustin J;
Vincan, Elizabeth;
Phesse, Toby J

Publication type:

Article

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

Published in:

2017

By:

Kagey, Michael H;
He, Xi

Publication type:

journal article

Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.

Published in:

2017

By:

Lyou, Yung;
Habowski, Amber N;
Chen, George T;
Waterman, Marian L

Publication type:

journal article

Issue Information.

Published in:: British Journal of Pharmacology, 2017, v. 174, n. 24, p. 4541, doi. 10.1111/bph.13607
Publication type:: Article

Assembly and architecture of the Wnt/β-catenin signalosome at the membrane.

Published in:

2017

By:

DeBruine, Zachary J;
Xu, H E;
Melcher, Karsten

Publication type:

journal article

Correction.

Published in:: 2017
Publication type:: journal article

The Dickkopf1-cytoskeleton-associated protein 4 axis creates a novel signalling pathway and may represent a molecular target for cancer therapy.

Published in:

2017

By:

Kikuchi, Akira;
Fumoto, Katsumi;
Kimura, Hirokazu

Publication type:

journal article

Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors.

Published in:

2017

By:

Zimmerli, Dario;
Hausmann, George;
Cantù, Claudio;
Basler, Konrad;
Cantù, Claudio

Publication type:

journal article

Immuno-pharmacological characterization of group II metabotropic glutamate receptors controlling glutamate exocytosis in mouse cortex and spinal cord.

Published in:

British Journal of Pharmacology, 2017, v. 174, n. 24, p. 4785, doi. 10.1111/bph.14061

By:

Olivero, Guendalina;
Bonfiglio, Tommaso;
Vergassola, Matteo;
Usai, Cesare;
Riozzi, Barbara;
Battaglia, Giuseppe;
Nicoletti, Ferdinando;
Pittaluga, Anna

Publication type:

Article

Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis.

Published in:

2017

By:

Jensen, Brian C;
Parry, Traci L;
Huang, Wei;
Beak, Ju Youn;
Ilaiwy, Amro;
Bain, James R;
Newgard, Christopher B;
Muehlbauer, Michael J;
Patterson, Cam;
Johnson, Gary L;
Willis, Monte S

Publication type:

journal article

Characterization of a rat model of bortezomib-induced painful neuropathy.

Published in:

2017

By:

Duggett, Natalie A;
Flatters, Sarah J L

Publication type:

journal article

Transient receptor potential vanilloid 1 inhibitors block laparotomy- and opioid-induced infarct size reduction in rats.

Published in:

2017

By:

Heymann, Helen M;
Wu, Yun;
Lu, Yao;
Qvit, Nir;
Gross, Garrett J;
Gross, Eric R

Publication type:

journal article

WNT signalling: mechanisms and therapeutic opportunities.

Published in:

2017

By:

Schulte, Gunnar;
Bryja, Vitezslav

Publication type:

Editorial

Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.

Published in:

2017

By:

Mariotti, Laura;
Pollock, Katie;
Guettler, Sebastian

Publication type:

journal article

Molecular regulation and pharmacological targeting of the β-catenin destruction complex.

Published in:

2017

By:

Kappel, Eline C;
Maurice, Madelon M;
van Kappel, Eline C

Publication type:

journal article

'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.

Published in:

2017

By:

Ong, Mei S;
Cai, Wanpei;
Yuan, Yi;
Leong, Hin C;
Tan, Tuan Z;
Mohammad, Asad;
You, Ming L;
Arfuso, Frank;
Goh, Boon C;
Warrier, Sudha;
Sethi, Gautam;
Tolwinski, Nicholas S;
Lobie, Peter E;
Yap, Celestial T;
Hooi, Shing C;
Huang, Ruby Y;
Kumar, Alan P

Publication type:

journal article

Works matching IS 00071188 AND DT 2017 AND VI 174 AND IP 24

Shikonin inhibits myeloid differentiation protein 2 to prevent LPS-induced acute lung injury.

Finding the needle in the haystack: systematic identification of psychobiotics.

Mirabegron: potential off target effects and uses beyond the bladder.

No pain, no gain: balancing central versus peripheral benefits of analgesics in the age of the opioid crisis.

VPAC<sub>1</sub> and VPAC<sub>2</sub> receptor activation on GABA release from hippocampal nerve terminals involve several different signalling pathways.

BIO 300, a nanosuspension of genistein, mitigates pneumonitis/fibrosis following high-dose radiation exposure in the C57L/J murine model.

Dopamine D<sub>2</sub> receptor signalling controls inflammation in acute pancreatitis via a PP2A-dependent Akt/NF-κB signalling pathway.

Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.

Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease.

WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.

Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.

Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.

Issue Information.

Assembly and architecture of the Wnt/β-catenin signalosome at the membrane.

Correction.

The Dickkopf1-cytoskeleton-associated protein 4 axis creates a novel signalling pathway and may represent a molecular target for cancer therapy.

Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors.

Immuno-pharmacological characterization of group II metabotropic glutamate receptors controlling glutamate exocytosis in mouse cortex and spinal cord.

Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis.

Characterization of a rat model of bortezomib-induced painful neuropathy.

Transient receptor potential vanilloid 1 inhibitors block laparotomy- and opioid-induced infarct size reduction in rats.

WNT signalling: mechanisms and therapeutic opportunities.

Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.

Molecular regulation and pharmacological targeting of the β-catenin destruction complex.

'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.